A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.

Source:http://linkedlifedata.com/resource/pubmed/id/12648074

Download in:

View as

General Info

PMID
12648074